Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Use of Synthetic Peptide Analogues to Localize Lecithin

Use of Synthetic Peptide Analogues to Localize Lecithin The major protein of high density llpoproteln (HDL), apolipoprotein (apo) A-l, is the major activator of the plasma enzyme lecithin:cholesterol acyltransferase (LCAT). A consensus amlno acid sequence has been defined for the eight, 22-resldue long, tandem amphlpathic helical repeats located in the carboxy-terminal region of apo A-l. A series of 22 and 44mer synthetic peptide analogues of the consensus domain, differing only In their 13th amlno acid residue, were prepared and tested for LCAT activation. One of the peptldes was found to equal apo A-l In LCAT activation. This is the first time a peptide activator for LCAT that rivals the activity of apo A-l in the vesicular and discoldal egg phosphatidylcholine assay systems has been synthesized. Based on these results, we propose that the major LCAT-actlvating domain of apo A-l resides in the 22mer tandem repeats, each containing Glu at the 13th residue and located between residues 66 and 121 In the native apolipoprotein. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Arteriosclerosis Wolters Kluwer Health

Use of Synthetic Peptide Analogues to Localize Lecithin

Download PDF
11 pages

Loading next page...
 
/lp/wolters-kluwer-health/use-of-synthetic-peptide-analogues-to-localize-lecithin-0ygoe6fZsu

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Copyright
© 1990 by American Heart Association, Inc.
ISSN
0276-5047

Abstract

The major protein of high density llpoproteln (HDL), apolipoprotein (apo) A-l, is the major activator of the plasma enzyme lecithin:cholesterol acyltransferase (LCAT). A consensus amlno acid sequence has been defined for the eight, 22-resldue long, tandem amphlpathic helical repeats located in the carboxy-terminal region of apo A-l. A series of 22 and 44mer synthetic peptide analogues of the consensus domain, differing only In their 13th amlno acid residue, were prepared and tested for LCAT activation. One of the peptldes was found to equal apo A-l In LCAT activation. This is the first time a peptide activator for LCAT that rivals the activity of apo A-l in the vesicular and discoldal egg phosphatidylcholine assay systems has been synthesized. Based on these results, we propose that the major LCAT-actlvating domain of apo A-l resides in the 22mer tandem repeats, each containing Glu at the 13th residue and located between residues 66 and 121 In the native apolipoprotein.

Journal

Arteriosclerosis – Wolters Kluwer Health

Published: Jan 1, 1990

There are no references for this article.